Medicines in clinical development

STO-REC-STAT01M2KJT2 National
12,900

Global · 2025

Medicines in clinical development worldwide stood at 12,900 in 2025 (IFPMA).

Original source
Publisher
IFPMA
Authority tier
T2 National
Locator
Enabling innovation: The R&D ecosystem for medicines and vaccines
Retrieved
15 Sep 2026
Status
Verified

What the source says

And in 2025, over 12,900 medicines were in clinical development worldwide, with three-quarters dedicated to non-communicable diseases (NCDs).

Verbatim extraction verified: The figure 12,900 is directly attested in the quoted passage (Enabling innovation: The R&D ecosystem for medicines and vaccines).

The figure above was extracted from this passage. If it does not match, the extraction is wrong and we want to know.

Other sources disagree

1 record reports a different value for this same indicator, region and period. We keep both rather than choosing or averaging. The disagreement is itself information.

ValueDivergenceSource organisationDocumentLocatorDetails
8,000-38.0%PhRMAResearch & DevelopmentPolicy FrameworkOpen record

Cite this figure

Published under CC BY 4.0. Attribute the original publisher; the citations below do that for you and link to this permanent record.

APA
IFPMA. (2025). Enabling innovation: The R&D ecosystem for medicines and vaccines. Retrieved September 15, 2026, from https://www.ifpma.org/publications/enabling-innovation-the-rd-ecosystem-for-medicines-and-vaccines/. Via StatOrigin, https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGF0
MLA
IFPMA. "Enabling innovation: The R&D ecosystem for medicines and vaccines." 2025, https://www.ifpma.org/publications/enabling-innovation-the-rd-ecosystem-for-medicines-and-vaccines/. Accessed 15 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGF0.
Chicago
IFPMA. "Enabling innovation: The R&D ecosystem for medicines and vaccines." 2025. https://www.ifpma.org/publications/enabling-innovation-the-rd-ecosystem-for-medicines-and-vaccines/. Accessed September 15, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGF0.
BibTeX
@misc{ifpma2025medicinesbjmgf0, author = {{IFPMA}}, title = {Enabling innovation: The R\&D ecosystem for medicines and vaccines}, year = {2025}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGF0}, note = {Original source: https://www.ifpma.org/publications/enabling-innovation-the-rd-ecosystem-for-medicines-and-vaccines/. Accessed September 15, 2026.} }

Provenance and verification

Everything needed to check this number yourself, without taking our word for it.

Chain of Custody · Verification Audit
Record: STO-REC-STAT01M2KJ T2 National

Primary Source

Publisher
IFPMA · homepage ↗
Authority tier
Tier 2 · National Official
Report
Enabling innovation: The R&D ecosystem for medicines and vaccines
Type
Press release
Published
Locator
Enabling innovation: The R&D ecosystem for medicines and vaccines
Retrieved
15 September 2026
Link status
Reachable (HTTP 200)
Report licence
See source

Verification & Integrity

Audit status
Verified
Review protocol
Editorial review
Checked on
15 September 2026
Last revision
15 September 2026
Archival URI
/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGF0